CDKN2A and atherosclerosis: Similarly, p16-3MR mice with low density lipoprotein receptor (Ldlr) −/− background as well as p16Ink4a-ATTAC Ldlr−/− mice, removal of senescent cells prevented atherosclerosis development [33].